EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy

Robin Willixhofer iD, Massimo Mapelli iD, Nikita Baracchini iD, Nicola Campana, Teresa Maria Capovilla iD, Alessandro Nava, Elisabetta Salvioni, Carlo Vignati iD, Filippo Maria Rubbo iD, Damiano Magrì, Emiliano Fiori iD, Beatrice Pezzuto und 13 weitere

Journal of the American Heart Association · 21.04.2026 · 15 (8)

DOI: 10.1161/jaha.125.046438 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 21.04.2026. Verfasst von Robin Willixhofer und 24 weiteren Autor:innen. Beteiligte Einrichtung: Centro Cardiologico Monzino, IRCCS Milan Italy. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Exercise Test, Heart Rate, Exercise Tolerance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The RoMa classification, based on peak heart rate and oxygen pulse derived from cardiopulmonary exercise testing, was recently proposed to stratify patients with hypertrophic cardiomyopathy by physiological reserve during exercise. We aimed to externally validate RoMa in an independent multicenter cohort with hypertrophic cardiomyopathy and assess its association with long‐term clinical outcomes.

Methods

In this retrospective multicenter cohort study patients with hypertrophic cardiomyopathy, undergoing cardiopulmonary exercise testing, were consecutively enrolled. Patients were enrolled regardless of left ventricular outflow tract obstruction and were naïve to disease‐specific therapy (eg, mavacamten). Patients were categorized into RoMa I to IV based on percentage of predicted heart rate and oxygen pulse. The primary end point was a composite of all‐cause and cardiovascular death, sudden cardiac death, or aborted sudden cardiac death, heart failure–related hospitalization, stroke, systemic embolism, surgical myectomy, and heart transplantation.

Results

The study included 292 patients (age 51 [36–63] years, 70% male sex, 30% with obstructive left ventricular outflow tract). Functional capacity declined hierarchically across RoMa groups (peak oxygen uptake 29.2 to 17.9 mL/kg/min; P ‐trend

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicExercise TestHeart RateExercise ToleranceHumansRetrospective StudiesMaleFemaleRisk AssessmentMiddle AgedAdultRisk FactorsPredictive Value of TestsDeath, Sudden, CardiacTime FactorsVentricular Outflow Obstruction, LeftPrognosisOxygen Consumption

Stichwörter der Autor:innen

cardiopulmonary exercise testingheart ratehypertrophic cardiomyopathyprognosisstroke volume

Autor:innen und Institutionen

  • Centro Cardiologico Monzino, IRCCS Milan Italy.
  • Department of Clinical Sciences and Community Health, Cardiovascular Section University of Milan Milan Italy.
  • Cardiovascular Department Center for Diagnosis and Treatment of Cardiomyopathies Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste Trieste Italy.
  • Postgraduate School of Cardiovascular Medicine University of Trieste, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste Trieste Italy.
  • Department of Medical Sciences and Public Health University of Cagliari Cagliari Italy.
  • Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste Trieste Italy.

ORCID-Profile: Robin Willixhofer, Massimo Mapelli, Nikita Baracchini, Teresa Maria Capovilla, Carlo Vignati, Filippo Maria Rubbo, Emiliano Fiori, Irene Mattavelli, Pietro Palermo, Jeness Campodonico, Mauro Contini, Cosimo Carriere, Irena Tavčar, Maddalena Rossi, Marco Merlo, Gianfranco Sinagra, Piergiuseppe Agostoni

Zitieren

APA

Willixhofer, R., Mapelli, M., Baracchini, N., Campana, N., Capovilla, T. M., Nava, A., Salvioni, E., Vignati, C., Rubbo, F. M., Magrì, D., Fiori, E., Pezzuto, B., Mattavelli, I., Apostolo, A., Palermo, P., Campodonico, J., Contini, M., Costantino, S., Carriere, C., …, & Agostoni, P. (2026). RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy. Journal of the American Heart Association, 15(8). https://doi.org/10.1161/jaha.125.046438

Vancouver

Willixhofer R, Mapelli M, Baracchini N, Campana N, Capovilla TM, Nava A, et al. RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy. Journal of the American Heart Association. 2026;15(8). doi:10.1161/jaha.125.046438

BibTeX
@article{Willixhofer2026,
  author = {Willixhofer, Robin and Mapelli, Massimo and Baracchini, Nikita and Campana, Nicola and Capovilla, Teresa Maria and Nava, Alessandro and Salvioni, Elisabetta and Vignati, Carlo and Rubbo, Filippo Maria and Magrì, Damiano and Fiori, Emiliano and Pezzuto, Beatrice and Mattavelli, Irene and Apostolo, Anna and Palermo, Pietro and Campodonico, Jeness and Contini, Mauro and Costantino, Simona and Carriere, Cosimo and Tavčar, Irena and Rossi, Maddalena and Cadeddu Dessalvi, Christian and Merlo, Marco and Sinagra, Gianfranco and Agostoni, Piergiuseppe},
  title = {RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {8},
  doi = {10.1161/jaha.125.046438}
}
Kostenlos starten →